Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
20 April 2024
| m 00:40 | Cutaneous squamous cell carcinoma diffhist -140 Jwarner talk contribs | ||||
|
|
m 00:39 | Classical Hodgkin lymphoma 2 changes history +914 [Jwarner (2×)] | |||
| m |
|
00:39 (cur | prev) +69 Jwarner talk contribs | |||
| m |
|
00:37 (cur | prev) +845 Jwarner talk contribs | |||
| m 00:22 | Head and neck cancer diffhist +35 Jwarner talk contribs | ||||
| m 00:20 | Colorectal cancer diffhist +186 Jwarner talk contribs | ||||
| m 00:17 | Non-small cell lung cancer diffhist +251 Jwarner talk contribs | ||||
19 April 2024
| m 23:55 | Urothelial carcinoma diffhist 0 Jwarner talk contribs | ||||
|
|
m 23:50 | Melanoma 2 changes history +6 [Jwarner (2×)] | |||
| m |
|
23:50 (cur | prev) +3 Jwarner talk contribs →Regimen variant #1, 2 mg/kg q3wk {{#subobject:25a9fe|Variant=1}} | |||
| m |
|
23:49 (cur | prev) +3 Jwarner talk contribs →Regimen variant #2, indefinite {{#subobject:722e51|Variant=1}} | |||
| m 16:22 | B-cell acute lymphoblastic leukemia, pediatric diffhist +745 Jwarner talk contribs →References | ||||
| m 12:34 | Mantle cell lymphoma diffhist 0 Jwarner talk contribs →Lenalidomide monotherapy {{#subobject:b5de78|Regimen=1}} | ||||
|
|
m 12:32 | Head and neck cancer 3 changes history +1,820 [Jwarner (3×)] | |||
| m |
|
12:32 (cur | prev) +594 Jwarner talk contribs →Methotrexate monotherapy {{#subobject:0e90b2|Regimen=1}} | |||
| m |
|
12:25 (cur | prev) +293 Jwarner talk contribs →Cetuximab monotherapy {{#subobject:4b973b|Regimen=1}} | |||
| m |
|
12:24 (cur | prev) +933 Jwarner talk contribs →Docetaxel monotherapy {{#subobject:623c3f|Regimen=1}} | |||
| m 12:30 | Glioblastoma diffhist +280 Jwarner talk contribs →Carmustine & RT {{#subobject:ee9fbd|Regimen=1}} | ||||
| m 11:17 | Chronic lymphocytic leukemia diffhist +337 Jwarner talk contribs →Ofatumumab monotherapy {{#subobject:75bd7e|Regimen=1}} | ||||
18 April 2024
|
|
m 23:44 | Peripheral T-cell lymphoma 2 changes history +22 [Jwarner (2×)] | |||
| m |
|
23:44 (cur | prev) +3 Jwarner talk contribs →References | |||
| m |
|
23:44 (cur | prev) +19 Jwarner talk contribs →Gemcitabine monotherapy {{#subobject:7dbc1c|Regimen=1}} | |||
| m 23:43 | Peripheral T-cell lymphoma - historical diffhist +2 Jwarner talk contribs →References | ||||
15 April 2024
| 20:16 | Classical Hodgkin lymphoma, pediatric diffhist 0 Warner-admin talk contribs | ||||
| 20:07 | Hepatoblastoma diffhist -1 Warner-admin talk contribs | ||||
|
|
20:04 | Rhabdomyosarcoma, pediatric 4 changes history +7 [Jwarner; Warner-admin (3×)] | |||
|
|
20:04 (cur | prev) -29 Warner-admin talk contribs →Low Risk | ||||
|
|
20:03 (cur | prev) +17 Warner-admin talk contribs →Intermediate Risk | ||||
|
|
19:57 (cur | prev) +17 Warner-admin talk contribs →High Risk | ||||
| m |
|
17:02 (cur | prev) +2 Jwarner talk contribs | |||
| 20:01 | Gestational trophoblastic neoplasia diffhist -16 Warner-admin talk contribs | ||||
| 19:59 | Rhabdomyosarcoma, pediatric - historical diffhist 0 Warner-admin talk contribs | ||||
| 19:57 | Neuroblastoma - historical diffhist +18 Warner-admin talk contribs →High Risk | ||||
| m 19:20 | Multiple myeloma, consolidation and maintenance diffhist -1 Jwarner talk contribs →Thalidomide & Prednisolone (TP) {{#subobject:1agdc9|Regimen=1}} | ||||
| m 18:42 | Follicular lymphoma - historical diffhist +255 Jwarner talk contribs →131Iodine-Tositumomab monotherapy {{#subobject:f69726|Regimen=1}} | ||||
| m 17:48 | Breast cancer - historical diffhist -1 Jwarner talk contribs →CEF/CMF {{#subobject:682333|Regimen=1}} | ||||
| m 17:04 | CNS lymphoma diffhist +16 Jwarner talk contribs →Nordic Regimen, younger patients {{#subobject:e571ce|Regimen=1}} | ||||
14 April 2024
|
|
m 17:35 | Urothelial carcinoma - null regimens 2 changes history -27 [Jwarner (2×)] | |||
| m |
|
17:35 (cur | prev) -39 Jwarner talk contribs →Preceding treatment | |||
| m |
|
17:34 (cur | prev) +12 Jwarner talk contribs →Preceding treatment | |||
| m 17:35 | Urothelial carcinoma diffhist -13 Jwarner talk contribs →Preceding treatment | ||||
| m 17:33 | Testicular cancer diffhist +9 Jwarner talk contribs →Regimen variant #5, 45/500/100 (modified BEP) {{#subobject:fd61db|Variant=1}} | ||||
| m 17:31 | Osteosarcoma - null regimens diffhist +328 Jwarner talk contribs | ||||
| m 17:27 | Non-small cell lung cancer - historical diffhist -70 Jwarner talk contribs | ||||
| m 17:25 | Multiple myeloma - historical diffhist +74 Jwarner talk contribs | ||||
| m 17:23 | Multiple myeloma, consolidation and maintenance diffhist +140 Jwarner talk contribs | ||||
|
|
m 17:21 | Mantle cell lymphoma 2 changes history +35 [Jwarner (2×)] | |||
| m |
|
17:21 (cur | prev) +9 Jwarner talk contribs →Preceding treatment | |||
| m |
|
17:20 (cur | prev) +26 Jwarner talk contribs →Brexucabtagene autoleucel monotherapy {{#subobject:4z3u14|Regimen=1}} | |||
| m 17:19 | Low-grade glioma diffhist +10 Jwarner talk contribs →Regimen variant #3, continuous therapy {{#subobject:3871fe|Variant=1}} | ||||
| m 17:19 | Light-chain (AL) amyloidosis diffhist +24 Jwarner talk contribs →Relapsed or refractory | ||||
| m 17:16 | Glioblastoma diffhist +43 Jwarner talk contribs →Maintenance after first-line therapy | ||||
| m 12:49 | Ewing sarcoma diffhist +44 Jwarner talk contribs | ||||